Cadila Healthcare (₹470.3)

The stock of Cadila Healthcare gained 3 per cent on Tuesday, reinforcing the bullish momentum. Investors with a short-term view can consider buying the stock at current levels.

After a corrective decline from the new high of ₹497 registered in early May, the stock found support at its key long-term base zone between ₹430 and ₹440 last week. Subsequently, the stock bounced up forming a bullish engulfing candlestick pattern at this key support zone.

This pattern a bullish reversal pattern that has bullish implication. Extending the up move the stock gained 3 per cent and breached its 21 as well as 50-day moving average on Tuesday. With this rally, the stock appears to have resumed its medium-term uptrend that has been in place since January 2017 low of ₹334. The daily relative strength index is moving higher in the neutral region towards the bullish zone and the weekly RSI re-entered the bullish zone, strengthens the uptrend.

Both the long and intermediate-term trends are up for the stock. The short-term outlook is bullish. The stock can continue its up move and reach the price targets of ₹488 and ₹498 in the forthcoming trading sessions. Buy the stock with a stop-loss at ₹460.

(Note: The recommendations are based on technical analysis. There is a risk of loss in trading.)

Read the rest of this article by Signing up for Portfolio.It's completely free!

What You'll Get





MORE FROM BUSINESSLINE


 Getting recommendations just for you...
This article is closed for comments.
Please Email the Editor